Back to search

Article

Does Biological Therapy Protect against Severe COVID-19?

2020-06-24

Abstract excerpt

<h4>Objective</h4> To estimate COVID-19 infection incidence rate with severe affectation (requiring hospitalization) in patients with biological treatment due to rheumatoid arthritis (RA), psoriatic arthritis (PsA), spondyloarthritis (SpA), psoriasis (Ps), and inflammatory bowel disease (IBD) and compare it with incidence rate in the general population. <h4>Methods</h4> Retrospective observational study based on i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1eb8301d-92cc-5573-9c1d-2de51b6ef5bd
DOI
10.1101/2020.06.21.20136788
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Does Biological Therapy Protect against Severe COVID-19?DOI 10.1101/2020.06.21.20136788
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity
Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity
The impact of biologic treatment in psoriasis patients on COVID-19 infection: A single-center retrospective studySemantic proximity
Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity
Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platformSemantic proximity
UNVACCINATED PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES HAVE HETEROGENEOUS AND UNRELATED RISKS OF COVID INFECTION AND POOR OUTCOMESemantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeySemantic proximity
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugsSemantic proximity
Select a neighboring publication to make it the new centre.